DECHRA PHARMACEUTICALSDECHRA PHARMACEUTICALSDECHRA PHARMACEUTICALS

DECHRA PHARMACEUTICALS

No trades
See on Supercharts

DPH/N fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

DPH/N does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company